Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibody validation using ip-mass spectrometry

A mass spectrometry and antibody technology, which can be used in material testing products, instruments, measuring devices, etc., and can solve the problems of difficulty in filtering and interpreting mass spectrometry results.

Inactive Publication Date: 2019-03-01
PIERCE BIOTECHNOLOGY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Thus, mass spectrometry results from immunoprecipitated samples can be difficult to filter and interpret

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody validation using ip-mass spectrometry
  • Antibody validation using ip-mass spectrometry
  • Antibody validation using ip-mass spectrometry

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0120] Example 1. Selection of cell models and targets for IP-MS antibody validation

[0121] figure 1 A summary of the IP-MS antibody validation process is presented. First, protein targets and antibodies are selected for validation. An appropriate cell model believed to contain the protein target of interest is selected, cultured, and lysates prepared. A "deep dive" analysis of many different cell lines was performed to select an appropriate cell line for use with our initial IP-MS analysis. Target proteins are immunoenriched from cell lysates using antibodies believed to be specific for a certain target protein (eg via IP / Western blotting, but not verified via IP-MS). Following IP, samples were analyzed by MS and novel bioinformatics analyzes were performed. Qualitative and quantitative data pertaining to each antibody's ability to bind the target protein is captured by this process, as well as data pertaining to non-target interacting proteins, as well as non-specific ...

Embodiment 2

[0141] Embodiment 2.IP / MS scheme

[0142] Use the following method to use figure 1 The IP / MS protocol shown generated data in a number of different cell lines.

[0143] Antibodies against TP53, CDH1, CDH2 and CDKN1A were purchased from Thermo Fisher Scientific (ref. Figure 5A , 5B , 7A). Antibodies were screened and validated using the Thermo Scientific Pierce MS-Compatible Magnetic IP Kit (Protein A / G) (Thermo Fisher Scientific, PN: 90409) as described in the instruction manual. 500 μg of lysate and 5 μg of antibody were used for all experiments. The IP eluate was dried in a vacuum concentrator and the sample was processed by digestion in solution as recommended in the instruction manual (Thermo Fisher Scientific, PN: 90409). Dried digested samples were resuspended in 13 μL of 4% acetonitrile and 0.2% formic acid and transferred into autosampler vials followed by LC-MS analysis.

[0144] LC-MS Analysis of IP-MS Samples

[0145] Use with THERMO TM SCIENTIFIC TM Q EXA...

Embodiment 3

[0147] Example 3. Identification of targets by MS

[0148] Validation of antibodies was assisted using protein expression profiling from Example 1 and techniques from Example 2 using a protocol combining immunoprecipitation with mass spectrometry (IP-MS). A key benefit of antibody validation by IP-MS is the identification of the native target protein and its isoforms and modifications. As mentioned above, the MS results of this target identification can be assessed in several ways, including the number of unique peptides, protein sequence coverage, the number of spectra observed for peptides from the target protein (spectrum counts) or from detected peptides. Integrated MS signal intensities of a subset or all of the peptides. Regardless of the measurement protocol, the relative performance of various antibodies on the same target can be readily compared. For example, immunoprecipitation using 13 IP / Western blot validated antibodies against the p53 protein (TP53) was assesse...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates, in part, to compositions and methods for validating antibodies utilizing immunoprecipitation and mass spectrometry.

Description

technical field [0001] The present invention relates, in part, to compositions and methods for validating antibodies using immunoprecipitation and mass spectrometry. Background technique [0002] Antibodies are used in a wide range of research and diagnostic applications for the enrichment, detection and quantification of proteins and their modification. Tens of thousands of antibodies against thousands of proteins are commercially available and are used in a variety of applications including Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Flow Cytometry Chromatin IP (ChIP), enzyme-linked immunoassay (ELISA), and bead-based sandwich assays (such as Luminex). These antibodies can be monoclonal or polyclonal from different organisms, and they can be used to interrogate biological systems and signaling pathways, diagnose disease, and assess response to therapy (see Lipman, N.S. et al., ILAR Journal 46(3 ): 258-268 (2005)). [0003] Unfortunately, mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/537G01N33/68
CPCG01N33/537G01N33/6848G01N33/6878G01N33/5306G01N33/577
Inventor J·C·罗杰斯B·B·帕特尔G·波茨L·福斯特
Owner PIERCE BIOTECHNOLOGY